Intelligent Identification of Cerebrospinal Fluid for the Diagnosis of Parkinson’s Disease

Cerebrospinal fluid (CSF) biomarkers are more sensitive than the Movement Disorder Society (MDS) criteria for detecting prodromal Parkinson’s disease (PD). Early detection of PD provides the best chance for successful implementation of disease-modifying treatments, making it crucial to effectively i...

Full description

Saved in:
Bibliographic Details
Published inAnalytical chemistry (Washington) Vol. 96; no. 6; pp. 2534 - 2542
Main Authors Chen, Huiting, Guo, Siyun, Zhuang, Zehong, Ouyang, Sixue, Lin, Peiru, Zheng, Zhiyuan, You, Yuanyuan, Zhou, Xiang, Li, Yuan, Lu, Jiajia, Liu, Ningxuan, Tao, Jia, Long, Hao, Zhao, Peng
Format Journal Article
LanguageEnglish
Published United States American Chemical Society 13.02.2024
Subjects
Online AccessGet full text
ISSN0003-2700
1520-6882
1520-6882
DOI10.1021/acs.analchem.3c04849

Cover

More Information
Summary:Cerebrospinal fluid (CSF) biomarkers are more sensitive than the Movement Disorder Society (MDS) criteria for detecting prodromal Parkinson’s disease (PD). Early detection of PD provides the best chance for successful implementation of disease-modifying treatments, making it crucial to effectively identify CSF extracted from PD patients or normal individuals. In this study, an intelligent sensor array was built by using three metal–organic frameworks (MOFs) that exhibited varying catalytic kinetics after reacting with potential protein markers. Machine learning algorithms were used to process fingerprint response patterns, allowing for qualitative and quantitative assessment of the proteins. The results were robust and capable of discriminating between PD and non-PD patients via CSF detection. The k-nearest neighbor regression algorithm was used to predict MDS scores with a minimum mean square error of 38.88. The intelligent MOF sensor array is expected to promote the detection of CSF biomarkers due to its ability to identify multiple targets and could be used in conjunction with MDS criteria and other techniques to diagnose PD more sensitively and selectively.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ISSN:0003-2700
1520-6882
1520-6882
DOI:10.1021/acs.analchem.3c04849